CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $33,810 | +24.6% | 880 | -24.9% | 0.00% | – |
Q1 2023 | $27,129 | -9.6% | 1,172 | +0.6% | 0.00% | – |
Q4 2022 | $30,000 | +57.9% | 1,165 | +21.5% | 0.00% | – |
Q3 2022 | $19,000 | +11.8% | 959 | +1.5% | 0.00% | – |
Q2 2022 | $17,000 | +13.3% | 945 | 0.0% | 0.00% | – |
Q1 2022 | $15,000 | 0.0% | 945 | 0.0% | 0.00% | – |
Q4 2021 | $15,000 | +275.0% | 945 | +231.6% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 285 | -18.1% | 0.00% | – |
Q2 2021 | $5,000 | +400.0% | 348 | +435.4% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 65 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 65 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |